NeuroRx Says COVID-19 Drug Improves Survival If Overstretched ICUs Excluded

Will Seek EUA Shortly

 
• By Andrew McConaghie
ICU Covid
NeuroRx argues that ICUs overwhelmed by COVID-19 cases should be excluded from the trial - but the US FDA may not agree • Source: Getty Images

More from Business

More from Scrip